XERS Stock Summary and Trading Ideas (Xeris Biopharma Holdings | NASDAQ:XERS)

Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.

Xeris Biopharma Holdings trades on the NASDAQ stock market under the symbol XERS.

As of April 19, 2024, XERS stock price declined to $1.74 with 1,981,906 million shares trading.

XERS has a beta of 1.33, meaning it tends to be more sensitive to market movements. XERS has a correlation of 0.05 to the broad based SPY ETF.

XERS has a market cap of $244.39 million. This is considered a Small Cap stock.

Last quarter Xeris Biopharma Holdings reported $44 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $840,000 and met earnings estimates .

In the last 3 years, XERS stock traded as high as $4.98 and as low as $.97.

The top ETF exchange traded funds that XERS belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

XERS has underperformed the market in the last year with a price return of -22.3% while the SPY ETF gained +21.2%. XERS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.8% and -14.7%, respectively, while the SPY returned +3.0% and -4.5%, respectively.

XERS support price is $1.70 and resistance is $1.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XERS stock will trade within this expected range on the day.